Актуальный события, последние новости фармацевтической промышленности и производителей стран СНГ.
Вас может заинтересовать:
WEB only
Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…
WEB only
A constructive meeting between Biopharma and Site Head Stada Inna Udovenko took place on July 20, 2023. The goal was to discuss cooperation on testing Stada products, which will improve…
